Ultragenyx Pharmaceutical

US · RARE #3012 by market cap Listed 1970

14.89 +0.43 +2.97%

Live - 5344 symbols - heartbeat 271s ago · 2026-10-08 07:00

Pre-market 14.85 -0.27%

After-hours 14.85 -0.27%

Overnight 14.89 0.00%

Market cap: 1.47B
P/E (TTM): -2.55
P/B: -5.04
EPS: -5.83
Div yield: 0.00%
52W pos: 8%

Reader sentiment Are you bullish or bearish on RARE?

Anonymous reader poll. Unscientific, not investment advice.

About Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Founded: 2010
CEO: Dr. Emil D. Kakkis, M.D.,PhD
Employees: 1,371
Headquarters: Novato, California, United States of America
Fiscal year end: 12-31
Website: ultragenyx.com

Company profile

Exchange: US
Symbol: RARE
Market-cap rank: #3012
Listing date: 1970-01-01
Market cap: 1.47B
Float cap: 1.20B
Shares out: 98.59M
Float shares: 80.72M

Sectors & themes

Biotechnology Fractional Shares JP

Browse all sectors & themes

Quote time 2026-10-08 07:00:14 · For reference only, not investment advice and not tailored to your situation.